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The mammalian target of rapamycin (mTOR) pathway integrates multiple signals and regulates crucial cell functions via the molecular
complexesmTORC1 andmTORC2. These complexes are functionally dependent on their raptor (mTORC1) or rictor (mTORC2) subunits.
mTOR has been associated with oligodendrocyte differentiation and myelination downstream of the PI3K/Akt pathway, but the func-
tional contributions of individual complexes are largely unknown.We show, by oligodendrocyte-specific genetic deletionofRptor and/or
Rictor in the mouse, that CNS myelination is mainly dependent on mTORC1 function, with minor mTORC2 contributions. Myelin-
associated lipogenesis and protein gene regulation are strongly reliant on mTORC1. We found that also oligodendrocyte-specific over-
activation ofmTORC1, via ablation of tuberous sclerosis complex 1 (TSC1), causes hypomyelination characterized by downregulation of
Akt signaling and lipogenic pathways. Our data demonstrate that a delicately balanced regulation of mTORC1 activation and action in
oligodendrocytes is essential for CNSmyelination, which has practical overtones for understanding CNSmyelin disorders.
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Introduction
CNSmyelination requiresmultiple-level coordination from con-
trolling the proliferation and differentiation of oligodendrocyte
precursor cells (OPCs) to wrapping of myelin sheaths around
axons by mature oligodendrocytes as the prerequisite of rapid
saltatory nerve conduction. Unraveling the mechanisms linking
external signals to intracellular signaling and myelination is re-
quired for our understanding of oligodendrocyte biology and
neuron–glia interactions, which has practical implications for
treatments of demyelinating and dysmyelinating disorders and
enhancing repair.
The kinase Akt is critically involved in CNS myelination. Ex-
pression of constitutively active Akt in oligodendrocytes induces
hypermyelination (Flores et al., 2008) and the underlying mech-
anism has been linked to the mammalian target of rapamycin
(mTOR, also referred to as mechanistic target of rapamycin)
pathway (Narayanan et al., 2009), a crucial mediator of PI3K/Akt
signaling (Laplante and Sabatini, 2012). The two mTOR-
containing complexesmTORC1 andmTORC2 contain the func-
tionally required proteins raptor (regulatory associated protein
of mTOR) and rictor (rapamycin-insensitive companion of
mTOR), respectively. Akt–mTOR interactions are complex be-
cause mTOR acts downstream and upstream of Akt. Full Akt
activation requires phosphorylation of threonine 308 (T308) and
serine 473 (S473). PI3K signaling leads to phosphorylation of Akt
at T308 by PDK1, whereas mTORC2 activates Akt directly by
phosphorylating S473. Activated Akt can phosphorylate the tu-
berous sclerosis complex 1/2 (consisting of TSC1 and TSC2, also
called hamartin and tuberin, and TBC1D7; Dibble et al., 2012),
which then releases its inhibitory effect on Rheb (Ras homolog
enriched in brain), a GTPase that activatesmTORC1 (Huang and
Manning, 2009). Inactivating mutations in either TSC1/2 result
in the autosomal-dominant multisystem disorder tuberous scle-
rosis complex, which is associated with multiple CNS manifesta-
tions (Crino et al., 2006).
Experiments using rapamycin, an inhibitor of mTORC1 and
partial inhibitor of mTORC2 signaling, suggested that mTOR
regulates oligodendrocyte differentiation (Norrme´n and Suter,
2013; Wood et al., 2013). In addition, widespread conditional
Rheb1 inactivation in neural precursors causes CNSmyelination
deficits (Zou et al., 2011). Here, we examined the specific roles of
mTORC1 andmTORC2 in oligodendrocytes and myelination in
vivo. To this end, we analyzed mice lacking raptor (called raptor
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mutants hereafter) or rictor (called rictor mutants hereafter) in-
dividually or raptor and rictor together (called raptor/rictor mu-
tants hereafter) to assess potential compensatory effects and
possible cooperative functions. The mTORC1 inhibitor TSC1
(called TSC1 mutants hereafter) was also deleted to analyze con-
sequences of putativemTORC1 hyperactivation.We used condi-
tional gene ablation via Cre-mediated recombination under the
control of cyclic nucleotide phosphodiesterase (CNP) gene regu-
latory elements (Genoud et al., 2002; Lappe-Siefke et al., 2003),
together with conditional LoxP-based raptor, rictor, and Tsc1-
null alleles (Kwiatkowski et al., 2002; Bentzinger et al., 2008; Po-
lak et al., 2008). In parallel, we analyzed consequences of raptor
and/or rictor ablation in myelin maintenance (called induced
mutants thereafter) using inducible Cre-mediated recombina-
tion in adult oligodendrocytes (Plp1-CreERT2 (Leone et al.,
2003). Our results identify mTORC1 as crucial regulator of CNS
myelination, whereas mTORC2 plays subtle functional roles in
oligodendrocyte biology. Precisely controlled mTORC1 activa-
tion levels and actions in oligodendrocytes are critical for proper
CNS myelination, with implications for the etiology of tuberous
sclerosis complex.
Materials andMethods
Generation of conditional knock-out mice. Mice homozygous for floxed
alleles of Tsc1 (Tsc1lox/lox; JAX stock #005680; The Jackson Laboratory),
Rictor (Rictorloxp/loxp; Bentzinger et al., 2008), and/or Rptor (Rptorloxp/ loxp;
Polak et al., 2008) were crossed with mice expressing the Cre recombinase
under thecontrolof theCNPpromoter (CNP-Cre; Lappe-Siefkeet al., 2003)
or the Plp1 promoter (Plp1-CreERT2; Leone et al., 2003). Tissue from
S6K1;S6K2 double-null mice were a generous gift Dr. Mario Pende
(INSERM, Paris, France; Shima et al., 1998; Pende et al., 2004). Tissue
from Eif4ebp1;Eif4ebp2 double-null mice were a generous gift from Dr.
Nahum Sonenberg (McGill University, Montreal, Canada; Le Bacquer et
al., 2007). Animals of either sex were used for the study and animals not
carrying the Cre transgene were used as controls unless otherwise indi-
cated. Genotypes were determined by PCR using genomic DNA. Primer
sequences are listed inTable 1. Animal experimentswere approved by the
veterinary office of the Canton of Zurich, Switzerland.
Table 1. List of PCR primers
Target Forward primer Reverse primer Product (in bp)
Primers for genotyping
Raptor 5-ATGGTAGCAGGCACACTCTTCATG-3 5-GGGAGATGTGACCTTAACCAGCTTC-3 WT : 141
Flox : 228
Rictor 5-TTATTAACTGTGTGTGGGTTG-3 5-CGTCTTAGTGTTGCTGTCTAG-3 WT : 197
Flox : 295
TSC1 5-GTCACGACCGTAGGAGAAGC-3 5-GAATCAACCCCACAGAGCAT-3 WT : 193
Flox : 230
Cre 5-ACCAGGTTCGTTCACTCATGG-3 5-AGGCTAAGTGCCTTCTCTACA-3 KI : 200
CNPcre 5-GATGGGGCTTACTCTTGC-3 5-CATAGCCTGAAGAACGAGA-3 KI : 900
Primers for RT-PCR
GAPDH 5-CGTCCCGTAGACAAAATGGT-3 5-TTGATGGCAACAATCTCCAC-3
PLP 5-GTTCCAGAGGCCAACATCAAGCTC-3 5-AGCCATACAACAGTCAGGGCATAG-3
MOG 5-TGCACCGAAGACTGGCAGGAC-3 5-AAGGACCTGCTGGGCTCTCCT-3
MAG 5-TGCCTTCAACCTGTCTGTG-3 5-CGGGTTGGATTTTACCACAC-3
MBP 5-GGCCTCAGAGGACAGTGATG-3 5-TCTGCTGTGTGCTTGGAGTC-3
MRF 5-GTATGACGCTAACTACAAGGAGCTGCC-3 5-CGGTCACCTGGAAGTGGTTCTTCTTC-3
HMGCR 5-CACAATAACTTCCCAGGGGT-3 5-GGCCTCCATTGAGATCCG-3
SCAP 5-CTGCTACCCGCTGCTGAA-3 5-AGAATTCCACAGGTCCCGTTC-3
IDI1 5-TCAACTTCATGTTCACCCCA-3 5-GAGTTGGGAATACCCTTGGA-3
SCD1 5-CAGCCGAGCCTTGTAAGTTC-3 5-GCTCTACACCTGCCTCTTCG-3
S1P 5-GGTGCTGGAGTGCGGGGTTC-3 5-ACCCCAGGAAGTCTCCGGGC-3
S2P 5-TCACCAGTCCAGCAGCTAAGGA-3 5-GCCTCTGGGTCCAATGGCAGG-3
Lipin-1 5-GCTTTTGGGAACCGTGC-3 5-ACCACTTCGCAGAGCCGCAC-3
PGC-1 5-ACACACCGCAATTCTCCCTT-3 5-TTTGGCCCTTTCAGACTCCC-3
PPAR 5-ATTGAGTGCCGAGTCTGTGG-3 5-GCAAGGCACTTCTGAAACCG-3
Sox10 5-CATGTCAGATGGGAACCCAGAGCACC-3 5-TTGCCGAAGTCGATGTGGGGCTTC-3
YY1 5-AAGACCCTGGAGGGCGAGTT-3 5-TCCAGGAGGGAGTTTCTTGCCT-3
Olig2 5-CGCAGCGAGCACCTCAAATC-3 5-TCATCGGGTTCTGGGGACGA-3
Srebp2 5-CCC ACT CAG AAC ACC AAG CA-3 5-AGTAGCTCGCTCTCGTTGGC-3
Srebp1c 5-GCCATGGATTGCACATTTGA-3 5-TGGTTGTTGATGAGCTGGAGC-3
Srebp1a 5-GAACAGACACTGGCCGAGATG T-3 5-GGTTGTTGATGAGCTGGAGCA T-3
FASN 5-CAGCAGAGTCTACAGCTACCT-3 5-ACCACCAGAGACCGTTATGC-3
Rxr 5-GTTGGAGAGTTGAGGGACGA-3 5-GGGCATGAGTTAGTCGCAGA-3
Rxr 5-GTCCACAGGCATCTCCTCAG-3 5-ACTGGCATGAAAAGGGAGG-3
Rxr 5-CAAGGCTACTGAAGGGCTCA-3 5-GCAGCCAACATGTATGGAAA-3
Rar 5-GGGAGGGCTGGGTACTATCT-3 5-AGCACCAGCTTCCAGTCAGT-3
Rar 5-CTCTGTGCATTCCTGCTTTG-3 5-AAGTGCTTTGAAGTGGGCAT-3
Rar 5-CGAGCTGGTGCTCTGTGTC-3 5-ACCATTTGAGATGCTGAGCC-3
Lxr 5-GCCCTGCACGCCTACGT-3 5-TAGCATCCGTGGGAACATCA-3
Lxr 5-GCTGATGATCCAGCAGTTAG-3 5-CGGAGAAAGATCGTTTGTTG-3
Insig2a 5-CCCTCAATGAATGTACTGAAGGATT-3 5-TGTGAAGTGAAGCAGACCAATGT-3
Insig2 5-TGGGTACCACCATGCTGCGG-3 5-TACCCACGAACACCGCCACG-3
Insig1 5-TCGTTGGCATCAACCACGCCA-3 5-GGCCGCTTCGGGAACGATCA-3
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Electron microscopy. Tissue processing was performed as described
previously (Pereira et al., 2010).
Morphometric analysis. Transverse sections of spinal cords were ana-
lyzed at the junction level of the thoracic and lumbar vertebrae (T13–L1).
The ratio of the axon diameter/fiber diameter ( g-ratio) was measured in
pixels on EM photographs (ultrathin sections, 65 nm) using Adobe Pho-
toshop CS5 software and converted to micrometers. Axonal diameter
was measured in toluidine-blue-stained semithin sections (0.65m) us-
ing a light microscope (Axioplan 2; Carl Zeiss). To achieve this, all axons
were measured in a determined area (45  45 m) of the spinal cord
ventricular funiculus. Sections were taken at the junction of the thoracic
and lumbar vertebrae.
Immunohistochemistry. Mice were killed by intraperitoneal injection
of pentobarbital (150 mg/kg, Nembutal; Abbott Laboratories) and per-
fused with 4% paraformaldehyde (PFA). Spinal cords were dissected,
postfixed for 2 h in 4% PFA, washed in PBS, dehydrated in 30% sucrose
overnight, embedded in optimal cutting temperature medium, and
stored at 80°C. Cryosections (10 m thick, T13–L1) were permeabil-
ized and blocked for 1 h at room temperature (RT) in blocking buffer
(0.3% Triton X-100 and 5% bovine serum albumin in PBS) and incu-
bated with primary antibodies overnight at 4°C in blocking buffer. For
enhanced Tcf-4 and Ki67 immunostaining, slides were preincubated in
10mM citrate buffer, pH 6.5, for 5min at 95°C and thenwashedwith PBS
before blocking. All primary antibodies are listed in Table 2. After wash-
ingwith PBS, sectionswere incubatedwith secondary antibodies coupled
to Alexa Fluor 488 (1:200; Invitrogen) or Cy3 (1:250; Jackson Immu-
noResearch Laboratories) for 1 h at RT, washed in PBS, incubated for 5
min in DAPI, and mounted with IMMU-MOUNT (Thermo Scientific).
Staining was observed using a fluorescence microscope (Axioplan2 Im-
aging; Carl Zeiss). Images were digitized with with a Powershot G5 cam-
era (Canon) and acquired with Axio Vision 4.5 software (Carl Zeiss).
Images were processed (levels adjusted) using Photoshop CS5 (Adobe).
To assess double-positive phospho-S6 (P-S6)/CC1 or FASN/Olig2 cells,
three random areas were chosen from each of three different transverse
spinal cord sections derived from the junction of the thoracic and lumbar
vertebrae (three different animals per condition) and the number of
strongly P-S6- or FASN-positive (above a given threshold) cells of total
CC1- or Olig2-positive cells was established. For confocal analyses, im-
ages were acquired using a Leica SP2-AOBS confocal laser-scanning mi-
croscope equipped with an argon laser using the HCX PL APO CS 63
oil-immersion objective. After optimizing image parameters, a series of
2D images was collected to form 3D spatial data. Processed images were
obtained with Imaris software.
Western blot.Analyses were performedwith spinal cord lysates of post-
natal day 10 (P10) mutant mice and their littermate controls unless oth-
erwise indicated. Mice were killed and spinal cords were isolated. Whole
spinal cord protein extracts were used unless otherwise indicated. Spinal
cords were normalized byweight and homogenizedwith a chilledmortar
and pestle in RIPA lysis buffer containing the following: 50mMTris-HCl,
1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, and protease inhibi-
tor (Sigma-Aldrich); phosphatase inhibitor (Roche); urea lysis buffer
containing 8 M urea, 1% SDS, 5 mM DTT, 1 mM Tris-HCl, 10% glycerol,
and protease inhibitor (Sigma-Aldrich); and phosphatase inhibitor
(Roche). Extracts were processed using standard SDS-PAGE and West-
ern blotting procedures using precast Mini-PROTEAN TGX gels (Bio-
Rad). Equal volumes were loaded on the gels. Primary antibodies are
listed in Table 2. Secondary antibodies were obtained from Southern
Biotech and JacksonImmunoresearch Laboratories. Quantity One soft-
ware (Bio-Rad) was used for quantification.
qRT-PCR.Analyses have been conducted on RNA extracts from spinal
cords of P10 mutant mice and their littermate controls. Total RNA was
extracted using the Quiazol (QIAGEN) protocol. cDNA was produced
using Superscript III Reverse Transcriptase (Invitrogen). qRT-PCR anal-
ysis was performed on a Light Cycler 480 II (Roche) using LightCycler
SYBR Green I Master Mix. Primer sequences are listed in Table 1.
Lipid analysis. Chemicals were purchased either fromMerck KGaA or
Sigma-Aldrich. Lipid standards were obtained from Avanti Polar Lipids.
Spinal cords from P60 animals were isolated. Lipid extraction was per-
formed as described previously (Matyash et al., 2008). Internal standard-
ization and data acquisition by HPLC coupled to an FT-ICR-MS hybrid
mass spectrometer (LTQ-FT; Thermo Scientific) has been described pre-
viously (Fauland et al., 2011).Data processingwas performedusing Lipid
Data Analyzer software as described previously (Hartler et al., 2011), a
process that relies on exact mass and retention time. Annotation of lipid
species was according to the shorthand nomenclature of the Interna-
tional Lipid Classification andNomenclature Committee (Liebisch et al.,
2013).
Processing of lipid extracts. Lipid extracts were evaporated and resus-
pended in 1ml of chloroform/methanol (1/1; v/v). Each lipid extract was
then split for analysis of total fatty acids (FAs; 350 l), free FAs (200 l),
positive ESI LC-MS/MS (18 l), and negative ESI LC-MS/MS (18 l).
Lipid extracts for LC-MS/MS analysis were evaporated, spiked with a set
of internal standards (Table 3), and resuspended in 90l of chloroform/
methanol (1/1; v/v).
Chromatography with electron impact mass spectrometry of total FAs
(free esterified). Aliquots of lipid extracts were dried and suspended in
1 ml of methanolic NaOH. After 10 min of incubation at 80°C, samples
were cooled for 5min on ice, 1ml of BF3 was added, and themixture was
incubated for 10 min at 80°C. FA methyl esters were extracted with 1 ml
of saturated NaCl and 2 ml of hexane. The hexane phase was dried and
methyl esters dissolved in 1.5 ml of hexane.
A Trace-DSQGC-MS (Thermo Scientific) equipped with a TR-FAME
30 m column was used for analysis. Helium was used as carrier gas at a
Table 2. List of antibodies
Target Host Dilution Source
Antibodies for IHC
APC (CC1) Mouse 1:200 Abcam
FASN Rabbit 1:200
Ki67 Rat 1:25 DakoCytomation
P-S6 Rabbit 1:200 Cell Signaling Technology
Lipin-1 Rabbit 1:50
MBP Rat 1:200 AbD Serotec
NF-160 Mouse 1:200 Sigma
Olig2 Rabbit 1:500 Millipore
PDGFR Rat 1:100 BD Pharmingen
Tcf-4 Mouse 1:100 Millipore
Antibodies for WB
P-Akt S473 Rabbit 1:1000 Cell Signaling Technology
P-Akt T308 Rabbit 1:1000
Akt Rabbit 1:1000
P-4-EBP1 T37/46 Rabbit 1:1000
P-4-EBP1 S65 Rabbit 1:1000
4EBP1 Rabbit 1:1000
P-Erk1/2 T202/Y204 Rabbit 1:1000
Erk1/2 Mouse 1:1000
Lipin-1 Rabbit 1:1000
mTOR Rabbit 1:1000
P-S6 S235/236 Rabbit 1:1000
S6 Rabbit 1:1000
P-p70 S6K T389 Rabbit 1:1000
p70 S6K Rabbit 1:1000
TSC1 Rabbit 1:1000
TSC2 Rabbit 1:1000
Raptor Rabbit 1:200
Rictor Rabbit 1:200
MBP Rat 1:1000 AbD Serotec
-tubulin Mouse 1:10000 Sigma
PLP Rabbit 1:1000 Abcam
FASN Rabbit 1:1000
Scap isoform 4 Rabbit 1:500
SREBP2 Rabbit 1:200
MOG Mouse 1:500 Santa Cruz Biotechnology
SREBP1 K-10 Rabbit 1:50
Scap isoform 1 Goat 1:200
Antibodies to MAG were a generous gift from Dr Steven Scherer (University of Philadelphia, Philadelphia, PA);
antibodies to HMGCR and IDI1 were a generous gift from Dr. Werner Kovacs (ETH Zu¨rich, Switzerland).
8434 • J. Neurosci., June 18, 2014 • 34(25):8432–8448 Lebrun-Julien et al. •mTOR Signaling in CNS Myelination
flow of 1.3 ml/min, in split mode, at 250°C injector temperature. The
initial oven temperature of 150°C was held for 0.5 min and then the
temperature was increased to 180°C at a rate of 10°C/min. This was
followed by a further increase to 190°C at a rate of 0.5°C/min and then
increased to 250°C at a rate of 40°C/min and kept for 3 min. The mass
spectrometer was run in electron impact mode and FAs were detected in
full scan of m/z 80–400. Source temperature was set to 250°C and the
transfer line temperature to 200°C.
Rapamycin treatment. Rapamycin was obtained from Calbiochem.
Tween 80% and polyethylene glycol PEG-400 were obtained from
Sigma-Aldrich. Rapamycin was dissolved in a vehicle solution of 4%
ethanol, 5% PEG-400, and 5% Tween 80. Mice were administered daily
intraperitoneal injections of rapamycin (5 mg/kg body weight) from P3
to P10. At P10, mice were killed, perfused, and analyzed by electron
microscopy.
Statistical analysis. Prism 5 software (GraphPad) was used for statisti-
cal analyses. Data are shown as the mean SEM. Statistical significance
was determined using an ANOVA test for groups of more than two and a
two-tailed Student’s t test for groups of two. Significance was set at *p
0.05, **p 0.01, and ***p 0.001.n refers to the number of independent
animals analyzed unless otherwise indicated.
Results
Conditional deletion of Rptor in the oligodendrocyte lineage
affects the timing of myelination and leads to persistent
hypomyelination
To address the functions of raptor, rictor, and raptor/rictor in
oligodendrocytes during CNS myelination, we generated mice
lacking these proteins in the oligodendrocyte lineage using Cre-
loxP technology (Fig. 1A). As expected, Western blot analysis of
microdissected spinal cord white matter fragments revealed
strong reduction of the target protein(s) in the corresponding
mutants compared with controls (Fig. 1B). To obtain a first over-
view of the consequences of raptor/rictor loss, we used immuno-
histochemistry on spinal cord sections of raptor/rictor mutants.
Staining for myelin basic protein (MBP) at P10 exposed an over-
all much reduced myelinated area and more sparse myelin label-
ing in mutants compared with littermate controls (Fig. 1C).
Subsequently, we started a systematic investigation by carrying
out Western blot analysis of P10 spinal cord homogenates of the
different mutants compared with controls. MBP, myelin oligo-
dendrocyte glycoprotein (MOG), myelin-associated glycopro-
tein (MAG), and proteolipid protein (PLP) levels were all
reduced in P10 raptor and raptor/rictor mutants, whereas no
significant changes (but a consistent trend to reductions) were
detected in rictor mutants (Fig. 1D). To corroborate these data at
the mRNA level, we performed qRT-PCR analysis for the same
targets and found strong reductions of MOG, MAG, and PLP in
raptor and raptor/rictor mutants compared with controls (Fig.
1E). Small but significant reductions were also detectable for the
mRNAs of MOG and PLP in rictor mutants. In contrast, MBP
mRNA levels were unchanged in all mutants, consistent with the
interpretation that altered posttranscriptional regulation ofMBP
causes the reductions observed at the protein level in raptor and
raptor/rictor mutants.
Next, we analyzed morphological changes in our mutants.
Consistent with the lower amount of myelin proteins present,
ultrastructural analysis of P10 spinal cord ventral funiculi re-
vealed strongly reduced myelin thickness in raptor and raptor/
rictor mutants compared with controls (Fig. 1F). These
alterations persisted into adulthood (P60, 6 months old). Upon
qualitative inspection, changes in myelin thickness were less ob-
vious in rictor mutants. Morphometric quantification by g-ratio
analysis (axon diameter/axon plus myelin diameter), however,
revealed a slightly but significantly increased g-ratio (indicating
thinner myelin) for P10 rictor mutants compared with controls
(Fig. 1F,G). This rictor-dependent hypomyelination was tran-
sient and fully recovered at later time points analyzed (P60, 6
months old). In raptor and raptor/rictor mutants, the g-ratios
remained abnormally high throughout development and in
adulthood (Fig. 1F,G). CNS hypomyelination was not restricted
to the spinal cord, because cerebella of P60 raptor and raptor/
rictor mutants were also similarly affected (Fig. 1H). In addition,
we quantified the fraction ofmyelinated axons and found a lower
percentage in P10 raptor and raptor/rictor mutants compared
with controls (Fig. 1I), indicating that raptor/mTORC1 regulates
myelination initiation. Furthermore, quantification of axonal di-
ameter showed a lower average in P60 mutants versus controls,
including the rictor mutants, albeit to a lesser extent (Fig. 1H, J).
These findings draw a parallel to previous studies in the PNS
showing that lack of mTOR protein in Schwann cells affects ax-
onal diameter (Sherman et al., 2012).
In summary, altered initiation ofmyelination and hypomyeli-
nationwere associatedwith reducedmyelin protein expression in
our mutants. The effects were strong in raptor mutants, indicat-
ing that raptor/mTORC1 is the main crucial determinant of
mTOR signaling in oligodendrocytes. In rictor mutants, the ef-
fects were small, often showing a tendency not reaching statistical
significance. In raptor/rictor mutants, there was a general trend
toward additive effects. Therefore, it appears likely that also ric-
tor/mTORC2 in oligodendrocytes is critically involved in CNS
myelination, although to a much lesser extent compared with
raptor/mTORC1.
Combined loss of raptor and rictor is required to impair OPC
differentiation and maturation
The mTORC1 inhibitor rapamycin can block progression of
OPC differentiation at the late progenitor stage in vitro (Tyler et
al., 2009). Therefore, our findings of defects in the timing of CNS
myelination and the observed hypomyelination in early develop-
ment in the mutants might be at least partially explained by
oligodendrocyte differentiation deficiencies. Therefore, we ad-
dressed the functional role of mTORC1 and mTORC2 in OPC
survival, proliferation, and differentiation in vivo by analyzing
spinal cord sections of mutants and controls with established
oligodendrocyte lineage markers. Proliferation of cells of the oli-
godendrocyte lineage (Ki67/Olig2 cells) at P0 did not differ
among mutants and controls (Fig. 2A,B). Quantification of
Table 3. List of internal standards used in LC-MS
Product no. Shorthand nomenclature Amount/sample (pmol)
LM-1100 PE 12:0/13:0 160
LM-1102 PE 17:0/20:4 160
LM-1103 PE 21:0/22:6 160
LM-1104 PE 17:0/14:1 160
LM-1302 PS 17:0/20:4 240
LM-1300 PS 12:0/13:0 240
LM-1304 PS 17:0/14:1 240
LM-1000 PC 12:0/13:0 200
LM-1002 PC 17:0/20:4 200
LM-1003 PC 21:0/22:6 200
LM-1004 PC 17:0/14:1 200
LM-1601 LPC 17:1 80
LM-4100 Cholesterol (D7) 6400
LM-6002 Sphingolipid mix I 120
LM-1500 PI 12:0/13:0 320
LM-1502 PI 17:0/20:4 320
LM-1504 PI 17:0/14:1 320
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Figure 1. Myelination deficiencies due to mTORC1 or mTORC2 inactivation. A, Regulatory elements of the CNP promoter drive the expression of Cre in oligodendrocytes. Schematics map of the
Rptor andRictor allele depicts the location of the loxP sequences.B,Microdissected fragments of the spinal cordwhitematterwere analyzedbyWestern blot to confirm the loss of raptor and/or rictor
in the conditional knock-out tissue. C, Transverse sections of the spinal cord from P10 raptor/rictor mutants and littermate controls were immunolabeled for MBP (green), neurofilament 160 (red),
andDAPI (blue).Whitematter area is reduced in raptor/rictormutantwith lower density ofMBP staining (red double-sided arrows). Scale bar, 200mD,Western blot analysis of spinal cord lysates
shows a striking reduction of the myelin proteins MBP, MOG, MAG, and PLP in raptor and raptor/rictor mutants when normalized to-tubulin. E, Levels of transcripts encoding myelin proteins
analyzed by qRT-PCR reveal significant reductions ofMOGandPLP in allmutants, reducedMAGexpression in raptor and raptor/rictormutants, andnodifference forMBP in (Figure legend continues.)
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Olig2 cells through postnatal development (P0, P10, P60; Fig.
2C) showed that oligodendrocyte-specific ablation of raptor, ric-
tor, or both had no significant effects on OPC/oligodendrocyte
cell numbers, which is consistent with the results of in vitro stud-
ies (Tyler et al., 2009). Next, we quantified OPCs specifically by
counting Olig2/PDGFR cells. Consistently, from P0 to P60,
only raptor/rictor double mutants contained significantly higher
numbers of OPCs compared with controls and single mutants
(Fig. 2D). Using Tcf-4 as marker of late progenitors to premyeli-
nating oligodendrocytes (Fancy et al., 2011), we found a signifi-
cant reduction of Olig2/Tcf-4 cells in P10 raptor/rictor
mutants only, with tendencies toward decreases at P0 and P60 as
well (Fig. 2E). Quantification of CC1/Olig2mature oligoden-
drocytes revealed lower numbers in raptor/rictor mutants from
birth to adulthood (Fig. 2F). Together, these results suggest
synergistic contributions of mTORC1 and mTORC2 to oligo-
dendrocyte maturation, because only the raptor/rictor double-
mutant mice were affected by significantly impaired
oligodendrocyte differentiation. To follow up on the underlying
molecular mechanism, we used qRT-PCR to analyze the expres-
sion of transcription factors crucially involved in oligodendro-
cyte maturation. Analysis of P10 spinal cords revealed strongly
decreased levels of SOX10, MRF, and Olig2, not only in raptor/
rictor mutants, but also in raptor mutants (Fig. 2G). YY1 levels
remained unchanged. We interpret these data as meaning that
the examined transcription factors not only regulate oligoden-
drocyte differentiation (significantly changed in raptor/rictor
mutants only), but also myelination per se, which is strongly
altered in both raptor/rictor and raptor mutants at P10.
mTORC1 function in oligodendrocytes is required for the
maintenance of myelinated fibers
A dynamic turnover of myelin membranes throughout the lifes-
pan has been suggested (Ando et al., 2003) and was supported by
recent evidence of CNSmyelin remodeling in the adult (Young et
al., 2013). Furthermore, the major CNS myelin regulator MRF
(the expression of which is reduced in raptor and raptor/rictor
mutants; Fig. 2G), is required to maintain adult myelinating oli-
godendrocytes, providing further evidence for ongoing crucial
dynamic renewal processes (Koenning et al., 2012). Therefore, we
assessed the overall requirements for mTOR signaling in adult
oligodendrocytes. To achieve this goal, we used tamoxifen-
inducible PLP1-CreRT2mice (Fig. 3A,B) combined with condi-
tional Rptor, Rictor, and Rptor/Rictor double-null alleles to
disrupt mTOR signaling and components thereof in oligoden-
drocytes after establishedmyelination. After induction of recom-
bination in 2-month-old mice, we confirmed loss of the
corresponding proteins (Fig. 3C) and analyzed the animals 12
months later by spinal cord ventral funiculus morphometry (Fig.
3D,E). Although the g-ratio in raptor mutants was slightly but
significantly higher than in controls and rictor mutants, raptor/
rictor doublemutants showed amore pronounced hypomyelina-
tion. In addition, analysis of the average axonal diameters
revealed significant reductions in all induced mutants (Fig. 3F),
comparable to our findings in development. We conclude that
mTOR signaling in oligodendrocytes is required to mantain the
full integrity of myelinated fibers. Axons depend on healthy oli-
godendrocytes in various ways, including metabolic support
(Nave, 2010; Morrison et al., 2013). Which specific aspects are
disturbed by defective mTOR signaling in oligodendrocytes re-
mains to be determined.
mTOR signaling in raptor, rictor, and raptor/rictor mutants
To unravel themolecularmechanisms that underlie the observed
phenotypes along mTOR signaling, we analyzed spinal cord ho-
mogenates of P10 mice using Western blot analysis. Loss of rap-
tor, rictor, or raptor/rictor did not affect total mTOR protein
levels in the corresponding animals (Fig. 4A). Next, we examined
phosphorylation of mTOR downstream targets as reliable mea-
sures of mTOR activity regarding stimulation of protein transla-
tion (Roux and Topisirovic, 2012). Phosphorylation levels of the
main targets of mTORC1, including the ribosomal protein S6
kinase (S6K), its substrate ribosomal protein S6, and the initia-
tion factor 4E-binding protein 1 (4E-BP1), were drastically re-
duced in raptor and raptor/rictor mutants, but not in rictor
mutants (Fig. 4A). To corroborate our data and to show cell-type
specificity, we used P-S6 immunohistochemistry on P10 spinal
cord sections. CC1 oligodendrocytes showed strongly reduced
P-S6 levels in raptor and raptor/rictor mutants compared with
rictor mutants and controls (Fig. 4B). These findings were con-
firmed by quantifications (strongly P-S6/CC1 cells: 63.4 
2.1% for controls compared with 4.8 2.2% for raptor mutants,
p  0.001; 54.5  3.1% for rictor mutants, not significant; and
4.9  1.0% for raptor/rictor mutants, p  0.001). Our results
indicate that raptor ablation is sufficient to downregulate the
mTORC1 pathway in developing oligodendrocytes, whereas ab-
lation of rictor/mTORC2 does not affect mTORC1 signaling de-
tectably in this setting. Next, we hypothesized that the observed
reduced S6K activation in raptor mutants could be responsible
for the observed hypomyelination on its own via impaired pro-
tein synthesis. However, morphological g-ratio analysis of
2-month-old S6K1/2 double-null mice (Shima et al., 1998; Pende
et al., 2004) did not reveal detectable differences compared with
littermate controls (Fig. 4C), indicating that S6K alone is not
responsible for this phenotype. Following a related rational, we
performed a similar analysis using 2-month-old 4E-BP1/2
double-null mice (Le Bacquer et al., 2007). 4E-BP1 binds to the
translation initiation factor eIF4E, preventing its assembly into
the EIF4F initiation complex and so inhibiting cap-dependent
translation (Morita et al., 2013). Once phosphorylated by
mTORC1, 4E-BP1 dissociates from eIF4E and translation is acti-
vated. In the raptor and raptor/rictor mutants, 4E-BP1 phos-
phorylation levels were strongly reduced, presumably associated
with diminished translation. In contrast, translation might be
aberrantly regulated, possibly enhanced, in 4E-BP1/2 double-
null mice, potentially causing CNS myelination changes. How-
ever, we could not detect myelin alterations in such mice
(Fig. 4D).
The mTOR pathway is intimately linked with Akt signaling,
both upstream of mTORC1 and downstream of mTORC2
(Laplante and Sabatini, 2012). We found that total protein levels
4
(Figure legend continued.) any mutants. F, EM micrographs of the ventral funiculus of spinal
cords showing thinnermyelin in the raptor/rictor and raptormutants at all ages examined (P10,
P60, 6months). Shown are scatter plots of the g-ratios of individual fibers in relation to respec-
tive axon diameters (in micrometers) quantified at P10, P60, and 6 months from raptor/rictor
(blue triangles), raptor (green diamonds), rictor (black circles), and littermate controls (red
squares). Scale bars, 5 m. G, Average g-ratios at P10, P60, and 6 months. Rictor mutants
displayedaminor deficit inmyelin thickness (higherg-ratio) at P10,which recovered at P60and
6months.H, EMmicrographs of the cerebellum show thinnermyelin in raptor/rictor and raptor
mutants at P60. Scale bar, 2.5m. I, Percentage of myelinated fibers in the ventral spinal cord
funiculus was reduced in raptor and raptor/rictor mutants. Error bars represent SEM. n 3;
*p 0.05; **p 0.01; ***p 0.001. J, Quantification of axon number and axonal diameter
per defined area (45 45m) of the spinal cord ventral funiculus on cross-sections stained
with toluidine blue. Axons with diameter0.4mwere excluded.
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of Akt were not changed in raptor, rictor, and raptor/rictor mu-
tants compared with controls (Fig. 4E). As expected, however,
Akt phosphorylation at S473 was strongly impaired in rictor mu-
tants because this residue is phophorylated directly by mTORC2
(Fig. 4E), further confirming inactivation of the mTORC2 com-
plex by rictor deletion in the mutant. Raptor mutants showed a
twofold increase of P-Akt at S473, consistent with previous re-
ports demonstrating that specific inhibition of mTORC1 in-
creases Akt phosphorylation at S473 in a rictor-dependent
manner (Breuleux et al., 2009). Upstream of mTOR, Akt can be
phosphorylated at T308 through the action of insulin and various
growth factors via the PI3K pathway, often referred to as the
PI3K/Akt/mTOR pathway. Both raptor and raptor/rictor
mutants showed an increase in T308 phosphorylation. Such hy-
perphosphorylation has been attributed to the failure of raptor-
deficient cells to activate inhibitory feedback loops (Bentzinger et
al., 2008). A significant crosstalk exists between PI3K/Akt/mTOR
and Ras/MAPK pathways, which can influence each other both
negatively and positively (Aksamitiene et al., 2012). Because the
Erk1/2 MAPK pathway is required to achieve proper myelin
thickness (Ishii et al., 2012), wemeasured both total protein levels
and phosphorylation of Erk1/2 in raptor, rictor, and raptor/rictor
mutants compared with controls. No alterations could be de-
tected at either P10 or P30 (Fig. 4F).
mTORC1 regulates proper lipid biosynthesis in
myelinated fibers
Myelin is dependent on both its precise protein and characteristic
lipid contents. Lipids provide the basic building blocks of this
multilayered cell membrane structure and proteins contribute
the critical connections and regulators. Therefore, assessing the
role of mTOR in myelinating oligodendrocytes must include the
regulation of lipogenesis, a major function attributed to mTOR
signaling (Laplante and Sabatini, 2010; Lewis et al., 2011; Soli-
man, 2011; Lamming and Sabatini, 2013). Endogenous lipid syn-
thesis is mainly controlled by the SREBP family of transcription
factors (Horton et al., 2002), which regulate the expression of
genes encoding sets of enzymes required for lipid metabolism.
SREBP-1c mainly controls genes involved in FA synthesis.
SREBP-2 mainly regulates genes involved in cholesterol synthe-
sis. SREBP-1a targets both sets of genes. We started our analysis
by examining expression of SREBPs and their main targets in
raptor, rictor, and raptor/rictormutants (Fig. 5A,B). No changes
for SREBP1 proteins and the two transcripts encoding SREBP1a
and SREBP1c could be detected between mutants and controls.
However, Western blot and qRT-PCR analyses aimed at deter-
mining FA synthase (FASN) and stearoyl-CoA desaturase-1
(SCD1) levels, two main targets of SREBP1, revealed significant
reductions in raptor and raptor/rictor mutants. In the same mu-
tants, SREBP2 expression was also diminished at the protein and
mRNA levels, accompanied by reductions of the SREBP2 targets
HMG-CoA reductase (HMGCR) and isopentenyl-diphosphate
delta isomerase 1 (IDI1). In rictor mutants, we detected a small
but significant diminution of FASN and HMGCR mRNA levels.
Note that we used whole spinal cord extracts for these analyses;
therefore, contributions from cell types other than oligodendro-
cytes may have partially masked the degree of expression attenu-
ation at the cellular level in these assays. To address this issuewith
respect to FASN reduction, we performed immunohistochemis-
try on P10 spinal cord sections. In raptor and raptor/rictor mu-
tants, Olig2 oligodendrocytes showed strongly reduced FASN
staining compared with controls, rictor mutants, and non-
Olig2 cells present in the sections (Fig. 5C), corroborating and
Figure 2. Ablation of raptor/rictor affects OPC maturation. A, Immunostaining for the cell
proliferationmarker Ki67 combinedwith Olig2 staining on spinal cord transverse sections of P0
raptor/rictor mutants showed no difference compared with controls. Arrowheads indicate
double-labeled cells. Scale bars, 50mB, Percentage of Ki67-positive cells/Olig-2 positive cells
did not significantly differ amongmutants and controls. C–F, Transverse spinal cord sections at
the junction of thoracic and lumbar vertebrae (T13–L1) were used to count total numbers of
cells of the oligodendrocyte lineage (Olig2 staining; C), OPCs (PDGFR/Olig2 staining; D), pr-
emyelinating oligodendrocytes (Tcf-4/Olig2 staining; E), and mature oligodendrocytes (CC1/
Olig2 staining; F) at P0, P10, andP60. Allmutants showed the samenumber of oligodendrocyte
lineage cells. Only doublemutants (raptor/rictor) exhibited negative effects on OPCmaturation
(higher number of PDGFR cells, lower number of CC1 cells at all timepoints). Three sections
each from three mice of each genotype were analyzed. G, qRT-PCR for the transcription factors
SOX 10, MRF, and Olig2 showed a striking reduction in spinal cords of raptor/rictor and raptor
mutant. YY1mRNAdid not change in anymutants. Error bars represent SEM. n 3; *p 0.05;
**p 0.01; ***p 0.001.
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extending the Western blot data. These findings were further
confirmed by quantifications (strongly FASN/Olig2 cells:
85.3 3.0% for controls compared with 11.6 0.5% for raptor
mutants, p 0.001; 87.9 0.8% for rictor mutants, not signifi-
cant; and 7.5 2.0% for raptor/rictor mutants (p 0.001)).
Next, we approached how SREBP1 levels can be unchanged in
raptor and raptor/rictor mutants, whereas the main targets of
SREBP1 are reduced. Therefore, we examined major players in-
volved in the maturation and activation of SREBPs in mutants
and controls. This group included the SREBP cleavage-activating
protein (SCAP; a SREBP activator), insulin-induced gene 1 (In-
sig1), insulin-induced gene 2 (Insig2), site-1 protease (S1P),
site-2 protease (S2P), andLipin-1.No expression alterationswere
found, except for the known SREBP1 target Insig1 in raptor and
raptor/rictor mutants. However, this finding cannot explain the
downregulation of targets, because Insig1 inhibits translocation
of the SCAP/SREBP complex from the ER to the Golgi apparatus
(Fig. 5D; Yang et al., 2002). mTORC1 can control the SREBP
pathway by regulating the cellular localization of Lipin-1 via
phosphorylation (Peterson et al., 2011). Therefore, to gain fur-
ther insights into the connection between mTOR signaling and
SREBP regulation in oligodendrocytes, we analyzed Lipin-1 lo-
calization by immunohistochemistry on spinal cord sections in
raptor and raptor/rictor mutants (Fig. 5E). No changes were de-
tected compared with controls. We conclude that raptor/
mTORC1 function regulates lipid biogenesis in myelinated
oligodendrocytes in a complex manner that remains partially
unclear.
Disarray of lipid composition in raptor mutants
Because the biosynthesis of lipids inmyelinated fibers is regulated
by mTORC1 signaling, differences in raptor mutants would be
expected. In indirect support of this hypothesis, Schwann cells
lacking SCAP showed PNS hypomyelination that was character-
ized by lipid composition abnormalities (Verheijen et al., 2009).
Therefore, we performed quantitative lipid profiling of spinal
cords derived from raptor mutants. Robust changes were found
compared with controls (Figs. 6, 7). Essential FAs cannot be syn-
Figure 3. Role of mTORC1 andmTORC2 inmyelinmaintenance. A, PLP1 gene regulatory elements drive expression of a tamoxifen-activatable Cre fusion protein in oligodendrocytes. Schematic
mapof raptor and rictor alleles depicts the location of loxP sequences. Upon Cre-mediated recombination after tamoxifen injection, the genomic region located between loxP sites is excised, thereby
inactivating the conditional raptoror rictoralleles.B, Outlineof theexperimental procedure: raptor, raptor/rictor, and rictormutants carrying thePLP1-CreRT2allele and their littermate controlswere
injectedwith tamoxifen for 5 consecutive days at 2months of age and killed for analysis 12months later. C, Microdissected fragments of the spinal cordwhitematterwere analyzed byWestern blot
to confirm loss of targeted raptor and/or rictor in the conditional knock-outmice.D,g-ratio values for raptormutants showeda small but significant increase comparedwith control. The raptor/rictor
mutant display a strikingly higher average g-ratio compared with both controls and single raptor mutants. Scatter plot graphics of single fiber g-ratio measurements versus axonal diameter (in
micrometers) detailing themyelin thickness amongmutants and controls. Shown are raptor/rictor (blue triangles), raptor (green diamonds), rictor (black circles), and their littermate controls (red
squares).E, Representative electronmicrographsof the spinal cord ventral funiculus showing thinnermyelin of raptor/rictormutants and theminor effect in raptormutants. Scale bars, 2.5m.Error
bars indicate SEM. n 3; **p 0.01; ***p 0.001. F, Quantification of axonal diameters per defined area of the spinal cord ventral funiculus on cross-sections stainedwith toluidine blue. Axons
with diameter0.4mwere excluded. The average axonal diameter was lower in all mutants. Error bars indicate SEM. n 3; *p 0.05; **p 0.01; ***p 0.001.
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thesized by cells, so, as expected, their levels were unchanged in
raptor mutants. However, nonessential FAs, which can be pro-
duced by the organism itself, were reduced significantly. Analyz-
ing the levels of total FAs revealed a small increase in saturated
FAs and a shift from monounsaturated FAs to polyunsaturated
FAs. In addition, the C18:1/C18:2 ratio, a marker for progression
of myelination (Huether et al., 1986), was decreased in raptor
mutants (Fig. 6A). Total levels of phosphatidyl choline, phos-
phatidyl ethanolamine, phosphatidyl inositol, and phosphatidyl
serine lipids were not changed (Fig. 6B), although we detected
Figure 4. mTOR signaling pathway in raptor, rictor, and raptor/rictor mutants. A, Spinal cord lysates of raptor, rictor, and raptor/rictor mutants and littermate controls were analyzed by
immunoblotting to detectmTOR protein and phosphorylation levels of themainmTORC1 targets: P-S6K (T389), P-S6 (S235/236), and P-4E-BP1 (S65).B, Immunostaining on spinal cord transverse
sections revealed loss of P-S6 (red) in oligodendrocytes (marked by CC1; green) in raptor and raptor/rictormutants, but not in rictormutants and controls. Arrowheads indicate double-labeled cells.
Scale bars, 20m. C, g-ratio values did not differ in S6K1/2 double-mutant animals compared with their littermate controls. Scatter plot graphics showing individual measurements of g-ratios
versus axonal diameter (in micrometers) for S6K1/2 double mutants (black squares) and their littermate controls (red circles). D, Analogous analysis and outcome for 4E-BP1/2 double mutants as
in C. Black squares, 4E-BP1/2; red circles, controls. Error bars indicate SEM. n 3; *p 0.05. E, Western blot analysis of the phosphorylation state of Akt at T308 or S473. F, Western blot analysis
revealed no change of phosphorylation levels of Erk1/2 at P10 or P30, indicating no shift toward the Erk1/2-mitogen-activated protein kinase (MAPK) pathway. Error bars indicate SEM. n 3; *p
0.05; **p 0.01; ***p 0.001.
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Figure 5. mTORC1 regulates lipogenesis via SREBP transcription factors. A, Western blot analysis of protein levels of SREBPs and their main targets in raptor, rictor, and raptor/rictor
mutants. SREBP1 protein levels showed no change, whereas while its targets, FASN and SCD1, were reduced in raptor and raptor/rictor mutants. The same mutants showed a reduction
at the protein level for SREBP2 and its targets HMGCR and IDI1. B, qRT-PCR of SREBPS and their main targets. C, Transverse sections of spinal cords revealed reduced staining for FASN
(green) in oligodendrocyte lineage cells (Olig2, red) in raptor and raptor/rictor mutants. Arrowheads indicate cells positive for Olig2 and negative for FASN. Scale bars, 25m. Error
bars indicate SEM. n 3; *p 0.05; **p 0.01; ***p 0.001. D, Quantification of mRNA levels of key elements responsible for thematuration of the SREBPs did not display significant
changes compared with controls, except for Insig1, a target of SREBPs, in raptor and raptor/rictor mutants. E, Transverse sections of spinal cords double-labeled for Lipin-1 (green) and
the oligodendrocyte lineage marker Olig2 (red) shows no detectable nuclear localization of Lipin-1 in raptor/rictor mutants and no difference in the subcellular localization of Lipin-1
compared with controls. Scale bars, 50m.
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significant variations between individual
lipid species (Fig. 7B). Finally, cholesterol,
ceramide, sphingomyelin, and glycosylce-
ramide levels were severely reduced in
raptor mutant spinal cords (Figs. 6C, 7C).
Hyperactivation of mTORC1 via TSC1
ablation causes hypomyelination
We had shown that inhibiting mTORC1
by raptor ablation in oligodendrocytes
leads to hypomyelination. To evaluate the
opposite situation, hyperactivation of
mTORC1 specifically in oligodendro-
cytes, we crossed CNP-cremice with mice
carrying floxed alleles of the Tsc1 gene en-
coding the tuberous sclerosis 1 protein, an
inhibitor of mTORC1 (TSC1 mutants;
Fig. 8A). TSC1/2 stabilize each other crit-
ically as a physical and functional complex
(van Slegtenhorst et al., 1998). Because
disruption of the complex bymutations in
Tsc1 orTsc2 cause tuberous sclerosis com-
plex, our experimental design was also
expected to aid in the evaluation of
oligodendrocyte-specific contributions to
this syndrome. Western blot analysis of
microdissected fragments of spinal cord
white matter revealed loss of both TSC1
andTSC2 inTSC1mutants, as anticipated
(Fig. 8B). Morphological analysis showed
that mice with oligodendrocytes lacking
TSC1 were affected by hypomyelination
comparable to raptor mutants (Fig. 8C).
In addition, we found similar decreases in
the levels ofmyelin proteins (MBP,MOG,
MAG, and PLP) in TSC1 mutants as in
raptor mutants, shown by immunoblot-
ting (Fig. 8D). qRT-PCR analysis revealed
reduced MOG, MAG, PLP, but not MBP,
mRNA levels, as well as reduced transcript
levels of the key transcription factors
Sox10, MRF, and Olig2, but not YY1, a
pattern shared between TSC1 mutants
and raptor mutants (Fig. 8E,F). In contrast to raptor mutants,
however, the percentage of myelinated axons was not altered in
TSC1 mutants (18.1  4%) compared with controls at P10
(19.8  1.1%). These findings indicate that TSC1 function in
oligodendrocytes is required for propermyelination and point to
a crucial contribution of loss of TSC1 in oligodendrocytes to the
CNS myelination defects and their potential functional conse-
quences in tuberous sclerosis complex.
Next, we confirmed that TSC1 ablation leads to mTORC1
overactivation. In support of these expectations, S6K and its sub-
strate S6 were hyperphosphorylated in TSC1 mutants (Fig. 9A).
Surprisingly, the level of P-4E-BP1 was reduced, similar to raptor
mutants. Phosphorylation of Akt at T308 was also diminished,
consistent with high activation of S6K triggering negative feed-
back loops (Huang and Manning, 2009; Song et al., 2012). In
addition, phosphorylation of Akt at S473 was decreased in TSC1
mutants compared with controls (Fig. 9B). This finding is in
agreement with in vitro data demonstrating that TSC1/2 is re-
quired for proper activation of mTORC2, the complex responsi-
ble for phosphorylation of Akt at S473 (Huang et al., 2008).
Altered feedback signalingmay also contribute (Bentzinger et al.,
2013; Castets et al., 2013). Our results on mTOR signaling in
TSC1mutants are in agreement with earlier studies showing that
a lack of the TSC1/2 complex leads to mTORC1 activation and
defective PI3K-Akt signaling (Zhang et al., 2003). Next, we inves-
tigated the effects ofmTORC1overactivation on the lipid biosyn-
thesis pathway. Comparable to raptor mutants, SREBP2 and
SREBP targets were reduced at the protein and mRNA levels in
TSC1 mutants (Fig. 9C,D). Therefore, precisely balanced activa-
tion of mTORC1 appears to be essential for lipogenesis. Offering
a potential explanation for our results, Yecies et al. (2011) have
shown that Akt can directly negatively regulate transcription of
Insig2a, an inhibitor of SREBP maturation, whereas this Akt-
mediated transcriptional suppression is missing in TSC1-ablated
cells (Yecies et al., 2011). However, we found that Insig2a is a
liver-specific transcript (Yabe et al., 2003) that is not expressed in
the spinal cord (Fig. 9E). Furthermore, expression of the major
isoform, Insig2, was not altered in the spinal cords of all our
mutants (Figs. 5D, 9E,F).
Figure 6. Abnormal lipid composition in raptor mutant spinal cords. A, Quantification of total FAs (TFAs) showed a significant
reductionof nonessential FAs (N.Ess.FAs) in raptormutants,whereas the level of essential FAs (Ess.FAs) didnot change. Percentage
of saturated, monounsaturated, and polyunsaturated FAs indicated a shift from monounsaturated to polyunsaturated FAs. The
ratio of 18:1/18:2, relatively high in normalmyelin,was reduced inmutants.B, Phosphatidyl choline, phosphatidyl ethanolamine,
phosphatidyl inositol, and phosphatidyl serine levels showed no change between controls andmutants. C, Cholesterol, ceramides,
sphingomyelin, and glycosylceramideswere strongly reduced inmutant spinal cords. Lipid specieswere normalized to theweight
of the sample. Error bars indicate SEM. n 4; *p 0.05; **p 0.01; ***p 0.001.
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Figure7. Lipid species analysis of the raptormutant spinal cords.A, Quantification of the total FA (TFA) species.B, Quantification of the individual lipid species phosphatidyl choline, phosphatidyl
ethanolamine, phosphatidyl inositol, and phosphatidyl serine of raptor mutants compared with littermate controls. C, Quantification of the individual lipid species ceramides, sphingomyelin, and
glycosylceramides in raptor mutants. Lipid species were normalized to sample weight. Error bars indicate SEM. n 3; *p 0.05; **p 0.01; ***p 0.001.
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We reasoned that mechanisms independent of mTORC1 hy-
peractivation but dependent on Akt for the activation of the
SREBPs may explain the observed CNS hypomyelination in
oligodendrocyte-specific TSC1 mutants. Therefore, we treated
TSC1 mutant pups and their littermate controls from P3 to P10
with rapamycin, an inhibitor of mTORC1, to decrease mTORC1
activity. Analysis of g-ratios in spinal cords revealed that rapamy-
cin treatment led to a partial rescue of the phenotype, mainly
increasing myelination of larger axons (Fig. 9G). Rapamycin-
treated controls showed comparable g-ratio profiles to treated
TSC1 mutants, consistent with modulation of mTORC1 causing
the effects. Western blot analysis on spinal cord samples con-
firmed the ability of rapamycin injection to reduce the overacti-
vation of themTORC1 downstream targets in the TSC1mutants,
reducing the phosphorylation to the same level as the littermate
controls treated with rapamycin. We conclude that overactiva-
tion ofmTORC1mediated by TSC1 ablation in oligodendrocytes
is the main contributor to the observed CNS hypomyelination.
Discussion
In the present study, we show that mice lacking raptor in oligo-
dendrocytes exhibit robust CNS hypomyelination, likely due to
defects in lipogenesis and alterations in the expression of myelin
proteins and critical regulators. In contrast, analogous rictormu-
tants were only mildly and transiently affected in the early phase
of myelination. To cause significantly delayed OPC differentia-
tion, combined loss of raptor and rictor was required. In addi-
tion, our data suggest essential roles of the mTOR pathway in
myelinmaintenance. Finally, overactivation ofmTORC1, caused
by TSC1 ablation in oligodendrocytes, also resulted in thinner
myelin and defective lipogenesis, with implications for our un-
derstanding of tuberous sclerosis complex.
Studies with rapamycin have shown thatmTOR is a key factor
regulating oligodendrocyte differentiation in vitro. They have not
led to a consensus, however, about which stage(s) of oligoden-
drocyte differentiation is mainly dependent on mTOR signaling
(Tyler et al., 2009; Guardiola-Diaz et al., 2012). Because rapamy-
cin inhibits many (but not all) mTORC1 activities andmTORC2
is known to be insensitive to short-term rapamycin applications
but inhibited by prolonged treatments (Sarbassov et al., 2006),
the specific individual functional roles of mTORC1 and
mTORC2 in oligodendrocytes remained unclear. Here, we show
in vivo thatmTOR signaling is indeed crucial for oligodendrocyte
differentiation. Initial analyses revealed that proliferation and
numbers of oligodendrocyte lineage cells were not changed in
raptor, rictor, and raptor/rictor mutants in the ventral spinal
cord funiculus at birth, consistent with the available in vitro re-
sults (Tyler et al., 2009). Subsequently, we examined oligoden-
drocyte differentiation using marker proteins. We found
significant alterations only if raptor and rictor were lacking in
combination, even though deletion of raptor alone led to com-
Figure 8. Overactivation of mTORC1 caused by TSC1 ablation leads to hypomyelination. A, Regulatory elements of the CNP promoter drive the expression of Cre in oligodendrocytes. Schematics
map of the TSC1 allele depicts the location of loxP sequences. B, Microdissected fragments of the spinal cord white matter were analyzed by Western blot to confirm TSC1 loss in conditional
knock-outs. C, Higher g-ratio values of TSC1 mutants in the spinal cord ventral funiculi indicate hypomyelination compared with controls. Shown are scatter plot graphics of single fiber measure-
ments detailing the thinner myelin in TSC1 mutants (black squares) compared with littermate controls (red circles). D, Spinal cord lysates of TSC1 mutants revealed strongly reduced levels of the
myelin proteinsMBP,MOG,MAG, andPLP.E, qRT-PCR revealed reduced levels of themyelin proteinsMOG,MAG, andPLP in the TSC1mutants comparedwith controls,whereasMBPwasunchanged.
F, qRT-PCR of transcripts encoding SOX 10,MRF, and Olig2 showed significant reductions in the spinal cord of TSC1 mutants. YY1 mRNA levels did not change.
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parable decreases in transcription factors involved in oligoden-
drocyte differentiation such as SOX10, MRF, and Olig2. The
presence of detectable maturation defects exclusively in raptor/
rictor mutants is somewhat in contrast to the reduced number of
myelinated axons and the hypomyelination observed already in
single raptor mutants and the transient hypomyelination in ric-
tor mutants early in life. Therefore, our findings suggest complex
and partially intermingled roles ofmTORC1 andmTORC2 in the
Figure 9. TSC1mutant analysis.A, Phosphorylation levels ofmTORC1 downstream targets P-S6K (T389) and P-S6K (S235/236)were strongly upregulated, except for P-4E-BP1 (S65), whichwas
reduced.B, Phosphorylation of Aktwas decreased on both T308 and S473. C, As in the raptormutants, protein levels ofmain targets of SREBP and SREBP2 itself were reduced inmutants.D, qRT-PCR
of the SREBPs and their main targets. E, RT-PCR for Insig2a and Insig2 in raptor, rictor, raptor/rictor, TSC1mutant, and control spinal cords comparedwith liver positive control (ethidium-bromide-
stained agarose gel). F, qRT-PCR of Insig2 in TSC1mutants and control spinal cords. Error bars indicate SEM. n 3; *p 0.05; **p 0.01; ***p 0.001.G, Scatter plot graphics of g-ratios versus
diameter of axons (in micrometers) of animal treated with rapamycin from P3 to P10. Shown are controls (gray triangles) and TSC1 mutants (blue diamonds) compared with control animals (red
circles), raptor mutants (green diamonds), and TSC1mutants (black squares) without treatment. Error bars indicate SEM. n 3; *p 0.05; **p 0.01; ***p 0.001.H, Spinal cord samples of
rapamycin-treated TSC1 mutants and littermate controls showed the same downregulation of the main mTORC1 downstream targets.
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different steps of oligodendrocyte differentiation, maturation,
myelination initiation, and myelin growth. It is clear, however,
that both complexes together regulate oligodendrocyte matura-
tion, whereas mTORC1 signaling is the main regulator of myelin
sheath growth.
Akt is a major player in the regulation of CNS myelination,
presumably acting through activation of the mTOR pathway
(Norrme´n and Suter, 2013). Myelinating-glia-specific condi-
tional knock-out of PTEN (phosphatase and tensin homolog de-
leted on chromosome 10), an upstream inhibitor of PI3K/Akt
signaling, induced hypermyelination. This phenotype was likely
mediated by mTOR, because phosphorylation of S6K and S6
downstream of mTORC1 were increased and partial rescue with
rapamycin treatment was observed (Goebbels et al., 2010; Har-
rington et al., 2010). In addition, mice overexpressing constitu-
tively active Akt exhibitedCNShypermyelination associatedwith
mTOR pathway activation (Narayanan et al., 2009). Here, we
have targeted and inactived raptor/mTORC1 as a major sig-
naling hub downstream of Akt. In indirect agreement with
these previous studies, raptor mutants were affected by CNS
hypomyelination. TSC1 mutants were also hypomyelinated
despite hyperactivatedmTORC1 signaling through S6K.Another
common consequence of both mTORC1 deficiency or overacti-
vation was dowregulation of the SREBP pathway. The observed
dysregulation of SREBPs in raptor mutants is consistent with the
positive regulatory functions of mTORC1 in lipid biosynthesis
(Porstmann et al., 2008; Lewis et al., 2011). Furthermore, mTOR
has been shown to induce the expression of proteins involved in
lipogenesis during oligodendrocyte differentiation in vitro (Tyler
et al., 2011). However, we were puzzled by the downregulation of
SREBPs in the TSC1 mutant. Hyperactivation of downstream
targets of mTOR are characteristic in tuberous sclerosis complex
(Napolioni et al., 2009), but mTORC1 activation also induces
negative feedback loops acting on the PI3K/Akt pathway and
leading to defective Akt signaling (Song et al., 2012). A recent
study showed that SREBPs can be activated in TSC1-deficient
cells by amechanism independent ofmTORC1but dependent on
Akt and mediated by Insig2a (Yecies et al., 2011). Although we
did not find evidence that this mechanism acts in TSC1-null
oligodendrocytes, those results provided the proof-of-principle
that such mTOR-independent/Akt-dependent mechanisms ex-
ist. Similarmechanismsmay explain the difference in phenotypes
observed between models in which the PI3K/Akt pathway is ac-
tivated directly (mainly hypermyelination) and models in which
mTORC1 is activated by TSC1 ablation (mainly hypomyelina-
tion). Elucidating the specific mechanisms of SREBP activation
and its specific relation to PI3K/Akt/mTOR signaling in oligo-
dendrocytes will be an exciting challenge for the future.
Dysfunction of the SREBPpathway in bothTSC1- and raptor-
ablated mutants had direct and similar repercussions on the lev-
els of their targets. Most previous studies have focused on
SREBP1 activation by mTOR. In raptor mutants and TSC1-
mutant oligodendrocytes, we found that SREBP2 and its targets
were strongly downregulated. SREBP2 tightly regulates choles-
terol levels, consistent with the reduced levels of cholesterol pres-
ent in raptor mutant spinal cords. Cholesterol is essential for
membrane growth (Brown and Goldstein, 1999; Saher et al.,
2005) and the myelin sheath tolerates only a moderate variation
in cholesterol-protein ratio (Saher and Simons, 2010). However,
despite robust reductions in the levels of enzymes responsible for
cholesterol and lipid synthesis, themutant oligodendrocyteswere
still able to produce myelin, albeit with reduced thickness. It
remains to be shown whether uptake of external lipids may have
helped to compensate for the deficient lipid synthesis, as was
previously suggested in Schwann cells (Verheijen et al., 2009).
To model tuberous sclerosis complex due to loss of TSC1,
appropriate animal models have been generated (Meikle et al.,
2007; Goto et al., 2011; Carson et al., 2012; Mietzsch et al., 2013).
Invariably, myelin deficiencies were observed in these studies,
similar to the hypomyelination described in tuberous sclerosis
complex patients. None of these studies, however, addressed
whether lack of TSC1 specifically in oligodendrocytes contrib-
utes to the pathology. This led to speculations that signals
from other TSC1-deleted cells in the mutant CNS may impair
myelination (Wood et al., 2013).We showhere that TSC1 expres-
sion by oligodendrocytes is required for proper myelination, be-
cause oligodendrocyte-specific TSC1 deletion leads to robust
mTORC1-dependent hypomyelination. Minor contributions to
this phenotype due to reducedmTORC2 activity are conceivable,
because P-Akt S473 was diminished in TSC1 mutants and rictor
mutants showed transient hypomyelination.However,mTORC2
is unlikely to be majorly involved, because the hypomyelination
in TSC1 mutants was as robust as in raptor mutants and much
more extensive than in rictor mutants.
In conclusion, we identified here a critical role of mTORC1 in
governing correct protein and lipid synthesis, which is required
for proper CNS myelin formation and maintenance. mTORC2-
mediated signaling is a minor but important contributor. Bal-
anced mTOR signaling and strictly regulated activation of
mTORC1 in oligodendrocytes is required for myelination and
correct lipogenesis. Although this study has focused mainly on
development, it will be an important future task to evaluate the
different roles of mTORC1 and mTORC2 in the regulation of
demyelination and remyelination in diseases such as multiple
sclerosis, its experimental models, or after injury to assess poten-
tial therapeutic efficacies of treatments along themTOR signaling
pathway.
During the time when this manuscript was under review, two
related studies were published (Bercury et al., 2014; Wahl et al.,
2014) supporting that mTOR signaling, and in particular
mTORC1 signaling (Bercury et al., 2014), are critical for CNS
myelination.
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